CUP syndrome-diagnostics from the perspective of pathology

被引:2
|
作者
Pauli, Chantal [1 ,2 ]
机构
[1] Univ Spital Zurich, Inst Pathol Molekularpathol, Zurich, Switzerland
[2] Univ Spital Zurich, Inst Pathol Molekularpathol, Ramistr 100, CH-8091 Zurich, Switzerland
来源
RADIOLOGIE | 2023年 / 63卷 / 5期
关键词
Cancer of unknown primary; Neoplasm metastasis; Immunohistochemistry; Lineage differentiation; Molecular diagnostics; UNKNOWN PRIMARY SITE; IMMUNOHISTOCHEMICAL APPROACH; DIFFERENTIAL-DIAGNOSIS; IDENTIFICATION; CARCINOMA; CANCERS; VIMENTIN; BIOLOGY;
D O I
10.1007/s00117-023-01143-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Problem: Histologic and immunohistologic workup of tumor material from metastases of a previously unknown primary tumor is important for identifying their origin, but is often insufficient for this purpose without clinical oncologic and radiologic evaluation.Procedure: In the initial cancer of unknown primary (CUP) situation, histologic and immunohistochemical workup together with clinicoradiologic correlations contribute significantly to the identification of the primary tumor. There are now accepted guidelines to follow when there is an initial CUP situation. Molecular diagnostic tools can be used to investigate changes at the nucleic acid level, which can provide clues about the primary tumor, including potential targets for therapy. If, despite broad and interdisciplinary diagnostics, it is not possible to identify the primary tumor, the diagnosis is CUP syndrome. If a true CUP situation is present, it is important to assign the tumor to a tumor class or a specific therapy-sensitive subgroup as best as possible so that the best possible treatment can be given. However, for a final assignment to a primary tumor or a final classification as CUP, a comparison with medical oncological and imaging findings is indispensable.Conclusion: When CUP is suspected, close interdisciplinary collaboration between pathology, medical oncology, and imaging is essential to achieve a viable classification as CUP or identification of a presumptive primary tumor, in the interest of providing the most specific and effective therapy for affected individuals.
引用
收藏
页码:336 / 345
页数:10
相关论文
共 50 条
  • [21] Cervical CUP syndrome
    Mozet, C.
    Wichmann, G.
    Stumpp, P.
    Dietzsch, S.
    Dietz, A.
    ONKOLOGE, 2013, 19 (01): : 44 - 51
  • [22] CUP-Syndrom im HalsbereichCervical CUP syndrome
    Frederik Fries
    Der Radiologe, 2020, 60 (11): : 1047 - 1051
  • [23] Epidemiology of CUP syndrome in Germany
    Kraywinkel, Klaus
    Zeissig, Sylke Ruth
    ONKOLOGE, 2017, 23 (12): : 966 - 973
  • [24] Contemporary Diagnostics: Sarcoma Pathology Update
    Brooks, John S. J.
    Lee, Solomon
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (05) : 513 - 519
  • [25] Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome Additional Points From the Perspective of Ear, Nose, and Throat Medicine
    Iro, Heinrich
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (17): : 293 - 294
  • [26] Diagnostic lymph node extirpation in CUP syndrome - useful or damaging?
    Wirth, Markus
    Pigorsch, Steffi
    Strassen, Ulrich
    Johnson, Felix
    Pickhard, Anja
    Wirth, Magdalena
    ACTA OTO-LARYNGOLOGICA, 2018, 138 (10) : 926 - 929
  • [27] Radiologische Bildgebung beim CUP-SyndromRadiological imaging in CUP syndrome
    Felix T. Kurz
    Stefan Delorme
    Die Radiologie, 2023, 63 (5) : 346 - 353
  • [28] Meningioma: A Pathology Perspective
    Toland, Angus
    Huntoon, Kristin
    Dahiya, Sonika M.
    NEUROSURGERY, 2021, 89 (01) : 11 - 21
  • [29] Molecular diagnostics: a healthcare perspective
    Hall, AG
    Coulthard, SA
    Irving, JAE
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (01) : 13 - 16
  • [30] Molecular diagnostics: A historical perspective
    Tsongalis, Gregory J.
    Silverman, Lawrence M.
    CLINICA CHIMICA ACTA, 2006, 369 (02) : 188 - 192